A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab (Q34382125)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab |
scientific article |
Statements
1 reference
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab (English)
1 reference
Julie Roda
1 reference
Michael A Caligiuri
1 reference
Aruna Mani
1 reference
Donn Young
1 reference
Gini F Fleming
1 reference
Peter Kaufman
1 reference
Adam Brufsky
1 reference
Susan Ottman
1 reference
William E Carson
1 reference
Charles L Shapiro
1 reference
3 December 2008
1 reference
1 reference
117
1 reference
1
1 reference
83-89
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference